This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Affymetrix Inc.
Affymetrix Inc., a leading name in the biotechnology industry, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1992, the company has pioneered advancements in microarray technology, significantly impacting genomics and personalised medicine. Affymetrix is renowned for its innovative products, including GeneChip® microarrays and the Axiom® genotyping platform, which offer unparalleled accuracy and scalability for genetic analysis. These core services enable researchers to conduct high-throughput genomic studies, making Affymetrix a preferred choice among scientists and institutions worldwide. With a strong market position, Affymetrix has achieved numerous milestones, including collaborations with leading research organisations and contributions to significant scientific discoveries, solidifying its reputation as a key player in the life sciences sector.
DitchCarbon Score
How does Affymetrix Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Affymetrix Inc.'s score of 70 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Affymetrix Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Thermo Fisher Scientific Inc., which means that any climate commitments or emissions data may be inherited from its parent organisation. Affymetrix Inc. does not have documented reduction targets or specific climate pledges. However, it is important to note that the climate initiatives and performance metrics may be influenced by the sustainability strategies of Thermo Fisher Scientific Inc., which operates at a cascade level of 4 in relation to Affymetrix. As a subsidiary, Affymetrix may align with the broader climate commitments and targets set by Thermo Fisher Scientific, which are likely to include industry-standard practices for reducing greenhouse gas emissions across various scopes. However, without specific data or targets from Affymetrix itself, a detailed assessment of its individual climate commitments remains unavailable.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Affymetrix Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
